Last reviewed: June 26, 2026
Last updated: June 26, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.
Semaglutide is a GLP-1 receptor agonist originally designed for type 2 diabetes that has shown remarkable effectiveness for weight management when dosed appropriately. Unlike many weight loss medications, semaglutide's benefits increase gradually over 16 weeks of dose escalation, with clinical trials demonstrating that patients reach meaningful weight loss at various dose levels depending on their individual physiology. Understanding how semaglutide dosing works helps you and your healthcare provider develop a personalized treatment plan that maximizes benefits while minimizing side effects.
How Semaglutide Dosing Schedules Work
Semaglutide is administered as a weekly subcutaneous injection using a step-based titration protocol that spans 16 weeks before reaching a maintenance dose. The standard titration begins at 0.25 mg weekly for four weeks, then increases to 0.5 mg for four weeks, then 1.0 mg for four weeks, and finally 1.7 mg or 2.4 mg depending on clinical goals and tolerability. This gradual approach allows your body to adapt to the medication's effects on appetite signaling and glucose metabolism, reducing nausea and gastrointestinal side effects that commonly occur with rapid dose escalation.
The maintenance dose range for weight management typically falls between 1.7 mg and 2.4 mg weekly, though some patients achieve their target weight loss at lower maintenance levels. Your prescribing provider may pause dose escalation at any level if you experience significant side effects or if weight loss plateaus, allowing for extended treatment at a dose that feels sustainable. PlexusDx compounded semaglutide maintains flat pricing at $149 per month regardless of your dose level, meaning your cost never increases as your titration advances through the 16-week protocol.
Therapeutic Dose Ranges and Expected Outcomes
Clinical trials evaluating semaglutide for chronic weight management have demonstrated that doses of 1.0 mg weekly produce approximately 5-8% weight loss over 68 weeks, while the 2.4 mg weekly dose produces approximately 10-15% weight loss in similar timeframes. The 1.7 mg dose, positioned between these two levels, typically achieves 8-12% weight loss and represents a common maintenance target for patients seeking significant results with improved tolerability. Individual response varies considerably based on factors including baseline metabolic rate, adherence to lifestyle modifications, and genetic predisposition to GLP-1 and GIP receptor sensitivity.
Reaching your therapeutic dose does not happen overnight, and patience through the titration phase is essential for success. Many patients notice appetite reduction and early satiety beginning at the 0.5 mg dose, though more pronounced weight loss typically emerges once they reach 1.0 mg or higher. PlexusDx's Precision Peptide Genetic Test identifies your individual peptide pathway sensitivities across 14 metabolic systems, helping clarify which dose range may provide optimal benefit for your genetic makeup.
Maximizing Semaglutide Benefits Through Personalized Treatment
Optimizing semaglutide's effectiveness requires more than simply advancing through dose levels—it demands alignment with your unique metabolic genetics, lifestyle factors, and weight loss goals. PlexusDx integrates genetic insight into dose optimization by analyzing your FTO, MC4R, GLP1R, and GIPR variants, which directly influence how your body responds to GLP-1 signaling and energy balance regulation. Patients with specific genetic patterns may reach their plateau earlier at lower doses, while others may continue benefiting from dose advancement toward the 2.4 mg maximum.
Consistent lifestyle practices amplify semaglutide's effects regardless of your maintenance dose level. Maintaining adequate protein intake helps preserve muscle mass during weight loss, staying hydrated supports appetite signaling, and regular physical activity enhances metabolic benefit. Your PlexusDx provider reviews these lifestyle factors alongside your genetic profile and dose response, allowing real-time adjustments to maximize your trajectory toward sustainable weight loss without unnecessary dose escalation.
Why Compounded Semaglutide Offers Dosing Flexibility at Fixed Pricing
Compounded semaglutide from licensed 503A pharmacies provides the same active pharmaceutical ingredient as brand medications but with significant advantages in cost predictability and dose customization. PlexusDx partners exclusively with 503A compounding pharmacies that maintain pharmaceutical-grade standards, sterility, and potency verification—ensuring that your dose precision remains accurate whether you're at 0.25 mg or 2.4 mg weekly. All compounded medications through PlexusDx serve all 50 states without insurance requirements or membership fees, and treatment is HSA/FSA eligible, reducing your out-of-pocket burden.
The flat monthly pricing model at PlexusDx eliminates the financial penalty for dose optimization, making it feasible to find your therapeutic range without cost anxiety. Starting at $149 per month for compounded semaglutide injection, you gain access to prescription-strength weight loss therapy while progressing through your personalized titration schedule. This pricing transparency aligns your clinical and financial incentives, allowing your provider to recommend the dose that delivers maximum benefit for your physiology rather than the dose that minimizes cost.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the standard starting dose of semaglutide for weight loss?
The standard starting dose is 0.25 mg injected subcutaneously once weekly for the first four weeks. This low initial dose allows your body to adapt to GLP-1 receptor activation while minimizing nausea and gastrointestinal side effects. Your dose increases every four weeks according to your tolerance and response until reaching your therapeutic maintenance level, typically between 1.0 and 2.4 mg weekly.
How long does it take to reach the full therapeutic dose?
The standard titration protocol spans 16 weeks, with dose increases occurring every four weeks through the progression of 0.25 mg → 0.5 mg → 1.0 mg → 1.7 mg or 2.4 mg. Some patients may extend this timeline if side effects emerge, while others may pause at intermediate doses if weight loss goals are achieved. Your PlexusDx provider determines the appropriate pace based on your individual tolerability and clinical response.
Will my PlexusDx semaglutide price increase as my dose goes up?
No. PlexusDx compounded semaglutide maintains flat pricing at $149 per month regardless of your dose level throughout your entire titration and maintenance phase. Your dose may need to go up, but your price won't—allowing you to optimize your treatment without financial penalty. HSA and FSA accounts are also accepted, further reducing your actual out-of-pocket cost.
What happens if I experience side effects at a particular dose?
If side effects like nausea, vomiting, or gastrointestinal discomfort emerge, your PlexusDx provider can pause dose escalation, extend the time at your current dose level, or adjust your maintenance dose downward to a level that provides weight loss benefit with acceptable tolerability. Many patients find that remaining at 1.0 or 1.7 mg provides meaningful results with minimal side effects, and there's no clinical requirement to reach the maximum dose.
How does the Precision Peptide Genetic Test help optimize my semaglutide dosing?
PlexusDx's Precision Peptide Genetic Test analyzes your GLP1R, GIPR, FTO, and MC4R variants across 14 metabolic pathways, revealing your individual sensitivity to GLP-1 receptor activation and appetite-regulatory mechanisms. These genetic insights help your provider predict which dose range will likely deliver optimal benefit for your physiology, potentially reaching your weight loss goals at a lower dose or justifying advancement toward higher doses when indicated by your genetic profile. The test is available for $99 as an add-on after your first month of treatment.
Related Reading
Pricing and availability current as of June 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.
Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
When Does Mounjaro Start Working After Injection?
Navigating Ozempic Use with Diabetic Retinopathy: What You Need to Know